1. Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation
   Jing Zhou et al, 2008, Molecular Cancer Therapeutics CrossRef
2. Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis
   Rachel M. Locklin et al, 2007, Molecular Cancer Therapeutics CrossRef